Letter by De Servi and Navarese regarding article, "Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial"

Circulation. 2010 Sep 21;122(12):e461; author reply e462-3. doi: 10.1161/CIRCULATIONAHA.110.938621.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Hemorrhage / chemically induced*
  • Hemorrhage / mortality*
  • Heparin / adverse effects
  • Heparin / therapeutic use
  • Hirudins / adverse effects*
  • Humans
  • Kaplan-Meier Estimate
  • Myocardial Infarction / mortality
  • Myocardial Ischemia / drug therapy*
  • Peptide Fragments / adverse effects*
  • Peptide Fragments / therapeutic use
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Risk Factors
  • Time Factors

Substances

  • Anticoagulants
  • Hirudins
  • Peptide Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Recombinant Proteins
  • Heparin
  • bivalirudin